Skip to content
2000
Volume 25, Issue 2
  • ISSN: 1568-0096
  • E-ISSN: 1873-5576

Abstract

Background

Results from the TCGA database showed that phosphatidylinositol-specific phospholipase Cγ2 (PLCG2) expression level in Lung Adenocarcinoma (LUAD) was notably decreased compared to adjacent tissues, so we unveiled its role of LUAD.

Objective

This study aims to explore the expression and clinical significance of Phosphatidylinositol-specific phospholipase Cγ2 (PLCG2) in lung adenocarcinoma (LUAD) cells and its role in cell proliferation and metastasis.

Methods

Differential PLCG2 mRNA and protein levels between LUAD tissues and adjacent tissues were analyzed from the TCGA database, TIMER, and UALCAN database. Differentially expressed genes were screened for patients in the high and low PLCG2 mRNA expression groups by the R package as well as GSEA. The expression level of PLCG2 in LUAD cells was detected using qRT-PCR and CCK8, clone formation, Transwell, and Western blot assays.

Results

PLCG2 was lowly expressed in LUAD and did not significantly correlate with the prognosis of LUAD. PLCG2 expression levels varied significantly in terms of patients' gender, age, T, N, and pathological stage. GO/KEGG enrichment analysis showed that co-expression of PLCG2 was mainly associated with the immune response- regulating cell-surface receptors, and so on. GSEA analysis showed enrichment pathways of PLCG2-related differential gees were primarily associated with the olfactory transduction pathway, ribosome, . R software analysis revealed a significant correlation between PLCG2 expression and six types of immune-infiltrating cells, positively correlated with immune checkpoint-related genes and negatively regulated by tumor mutational load. Overexpressing PLCG2 showed reduced LUAD cell proliferation, clone formation, cell migration and invasion, and epithelial-mesenchymal transition-associated proteins, compared with the control group.

Conclusion

PLCG2 is lowly expressed in LUAD tissues and is involved in immune infiltration of LUAD, inhibiting LUAD cell proliferation and metastasis.

Loading

Article metrics loading...

/content/journals/ccdt/10.2174/0115680096307100240801095132
2024-08-16
2025-04-23
Loading full text...

Full text loading...

References

  1. SungH. FerlayJ. SiegelR.L. LaversanneM. SoerjomataramI. JemalA. BrayF. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J. Clin.202171320924910.3322/caac.21660 33538338
    [Google Scholar]
  2. ChenW. ZhengR. BaadeP.D. ZhangS. ZengH. BrayF. JemalA. YuX.Q. HeJ. Cancer statistics in China, 2015.CA Cancer J. Clin.201666211513210.3322/caac.21338 26808342
    [Google Scholar]
  3. ZhengM. Classification and pathology of lung cancer.Surg. Oncol. Clin. N. Am.201625344746810.1016/j.soc.2016.02.003 27261908
    [Google Scholar]
  4. JacksonJ.T. MulazzaniE. NuttS.L. MastersS.L. The role of PLCγ2 in immunological disorders, cancer, and neurodegeneration.J. Biol. Chem.2021297210090510.1016/j.jbc.2021.100905 34157287
    [Google Scholar]
  5. TsaiA.P. DongC. LinP.B.C. MessengerE.J. CasaliB.T. MoutinhoM. LiuY. OblakA.L. LambB.T. LandrethG.E. BisselS.J. NhoK. PLCG2 is associated with the inflammatory response and is induced by amyloid plaques in Alzheimer’s disease.Genome Med.20221411710.1186/s13073‑022‑01022‑0 35180881
    [Google Scholar]
  6. WenY. JingY. YangL. KangD. JiangP. LiN. ChengJ. LiJ. LiX. PengZ. SunX. MillerH. SuiZ. GongQ. RenB. YinW. LiuC. The regulators of BCR signaling during B cell activation.Blood Sci.20191211912910.1097/BS9.0000000000000026 35402811
    [Google Scholar]
  7. ShlomchikM.J. LuoW. WeiselF. Linking signaling and selection in the germinal center.Immunol. Rev.20192881496310.1111/imr.12744 30874353
    [Google Scholar]
  8. BabaY. KurosakiT. Impact of Ca2+ signaling on B cell function.Trends Immunol.2011321258959410.1016/j.it.2011.09.004 22000665
    [Google Scholar]
  9. van der LeeS.J. ConwayO.J. JansenI. CarrasquilloM.M. KleineidamL. van den AkkerE. HernándezI. van EijkK.R. StringaN. ChenJ.A. ZettergrenA. AndlauerT.F.M. Diez-FairenM. Simon-SanchezJ. LleóA. ZetterbergH. NygaardM. BlauwendraatC. SavageJ.E. Mengel-FromJ. Moreno-GrauS. WagnerM. ForteaJ. KeoghM.J. BlennowK. SkoogI. FrieseM.A. PletnikovaO. ZulaicaM. LageC. de RojasI. Riedel-HellerS. Illán-GalaI. WeiW. JeuneB. OrellanaA. Then BerghF. WangX. HulsmanM. BekerN. TesiN. MorrisC.M. IndakoetxeaB. CollijL.E. SchererM. Morenas-RodríguezE. IronsideJ.W. van BerckelB.N.M. AlcoleaD. WiendlH. StricklandS.L. PastorP. Rodríguez RodríguezE. BoeveB.F. PetersenR.C. FermanT.J. van GerpenJ.A. ReindersM.J.T. UittiR.J. TárragaL. MaierW. Dols-IcardoO. KawaliaA. DalmassoM.C. BoadaM. ZettlU.K. van SchoorN.M. BeekmanM. AllenM. MasliahE. de MunainA.L. PantelyatA. WszolekZ.K. RossO.A. DicksonD.W. Graff-RadfordN.R. KnopmanD. RademakersR. LemstraA.W. PijnenburgY.A.L. ScheltensP. GasserT. ChinneryP.F. HemmerB. HuismanM.A. TroncosoJ. MorenoF. NohrE.A. SørensenT.I.A. HeutinkP. Sánchez-JuanP. PosthumaD. ClarimónJ. ChristensenK. Ertekin-TanerN. ScholzS.W. RamirezA. RuizA. SlagboomE. van der FlierW.M. HolstegeH. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.Acta Neuropathol.2019138223725010.1007/s00401‑019‑02026‑8 31131421
    [Google Scholar]
  10. LiZ. ZhaoR. YangW. LiC. HuangJ. WenZ. DuG. JiangL. PLCG2 as a potential indicator of tumor microenvironment remodeling in soft tissue sarcoma.Medicine (Baltimore)2021100112500810.1097/MD.0000000000025008 33725976
    [Google Scholar]
  11. WangY. LinK. XuT. WangL. FuL. ZhangG. AiJ. JiaoY. ZhuR. HanX. CaiH. Development and validation of prognostic model based on the analysis of autophagy-related genes in colon cancer.Aging (Albany NY)20211314190281904710.18632/aging.203352 34315829
    [Google Scholar]
  12. ChanJ.M. Quintanal-VillalongaÁ. GaoV.R. XieY. AllajV. ChaudharyO. MasilionisI. EggerJ. ChowA. WalleT. MattarM. YarlagaddaD.V.K. WangJ.L. UddinF. OffinM. CiampricottiM. QeriqiB. BahrA. de StanchinaE. BhanotU.K. LaiW.V. BottM.J. JonesD.R. RuizA. BaineM.K. LiY. RekhtmanN. PoirierJ.T. NawyT. SenT. MazutisL. HollmannT.J. Pe’erD. RudinC.M. Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer.Cancer Cell2021391114791496.1810.1016/j.ccell.2021.09.00834653364
    [Google Scholar]
  13. YangY. YangY. HuangH. SongT. MaoS. LiuD. ZhangL. LiW. PLCG2 can exist in eccDNA and contribute to the metastasis of non-small cell lung cancer by regulating mitochondrial respiration.Cell Death Dis.202314425710.1038/s41419‑023‑05755‑7 37031207
    [Google Scholar]
  14. KrepischiA.C.V. MaschiettoM. FerreiraE.N. SilvaA.G. CostaS.S. da CunhaI.W. BarrosB.D.F. GrundyP.E. RosenbergC. CarraroD.M. Genomic imbalances pinpoint potential oncogenes and tumor suppressors in Wilms tumors.Mol. Cytogenet.2016912010.1186/s13039‑016‑0227‑y 26913079
    [Google Scholar]
  15. HongJ. BeharJ. WandsJ. ResnickM. WangL.J. DeLellisR.A. LambethD. CaoW. Bile acid reflux contributes to development of esophageal adenocarcinoma via activation of phosphatidylinositol-specific phospholipase Cgamma2 and NADPH oxidase NOX5-S.Cancer Res.20107031247125510.1158/0008‑5472.CAN‑09‑2774 20086178
    [Google Scholar]
  16. WoodsN.T. MonteiroA.N. ThompsonZ.J. AmankwahE.K. NaasN. HauraE.B. BegA.A. SchabathM.B. Interleukin polymorphisms associated with overall survival, disease-free survival, and recurrence in non-small cell lung cancer patients.Mol. Carcinog.20151117218410.1002/mc.22275
    [Google Scholar]
  17. ZhangZ. XuZ. WangX. WangH. YaoZ. MuY. MaZ. LiuZ. Ectopic Ikaros expression positively correlates with lung cancer progression.Anat. Rec. (Hoboken)2013296690791310.1002/ar.22700 23580163
    [Google Scholar]
  18. TakagiK. MikiY. OnoderaY. IshidaT. WatanabeM. SasanoH. SuzukiT. ARHGAP15 in human breast carcinoma: a potent tumor suppressor regulated by androgens.Int. J. Mol. Sci.201819380410.3390/ijms19030804 29534468
    [Google Scholar]
  19. KimJ.M. ParkJ. NohE.M. SongH.K. KangS. JungS. KimJ.S. ParkB.H. LeeY.R. YounH. Bruton’s agammaglobulinemia tyrosine kinase (Btk) regulates TPA induced breast cancer cell invasion via PLCγ2/PKCβ/NF κB/AP 1 dependent matrix metalloproteinase 9 activation.Oncol. Rep.20214555610.3892/or.2021.8007 33760219
    [Google Scholar]
  20. WatanabeD. HashimotoS. IshiaiM. MatsushitaM. BabaY. KishimotoT. KurosakiT. TsukadaS. Four tyrosine residues in phospholipase C-gamma 2, identified as Btk-dependent phosphorylation sites, are required for B cell antigen receptor-coupled calcium signaling.J. Biol. Chem.200127642385953860110.1074/jbc.M103675200 11507089
    [Google Scholar]
  21. ChiangC.Y. VeckmanV. LimmerK. DavidM. Phospholipase Cγ-2 and intracellular calcium are required for lipopolysaccharide-induced Toll-like receptor 4 (TLR4) endocytosis and interferon regulatory factor 3 (IRF3) activation.J. Biol. Chem.201228763704370910.1074/jbc.C111.328559 22158869
    [Google Scholar]
  22. VulinkA. RadfordK.J. MeliefC. HartD.N.J. Dendritic cells in cancer immunotherapy.Adv. Cancer Res.20089936340710.1016/S0065‑230X(07)99006‑5 18037410
    [Google Scholar]
  23. QuJ. ChengT. LiuL. HengJ. LiuX. SunZ. WangW. LiK. YangN. Mast cells induce epithelial-to-mesenchymal transition and migration in non-small cell lung cancer through IL-8/Wnt/β-catenin pathway.J. Cancer20191022556710.7150/jca.38671 31632500
    [Google Scholar]
  24. QuinquenelA. ForneckerL.M. LetestuR. YsebaertL. FleuryC. LazarianG. DilhuydyM.S. NolletD. GuiezeR. FeugierP. Roos-WeilD. WillemsL. MichalletA.S. DelmerA. HormigosK. LevyV. CymbalistaF. Baran-MarszakF. Prevalence of BTK and PLCG2 mutations in a real-life CLL cohort still on ibrutinib after 3 years: a FILO group study.Blood2019134764164410.1182/blood.2019000854 31243043
    [Google Scholar]
  25. JingH. ReedA. UlanovskayaO.A. GrigoleitJ.S. HerbstD.M. HenryC.L. LiH. BarbasS. GermainJ. MasudaK. CravattB.F. Phospholipase Cγ2 regulates endocannabinoid and eicosanoid networks in innate immune cells.Proc. Natl. Acad. Sci. USA202111841211297111810.1073/pnas.2112971118 34607960
    [Google Scholar]
  26. Condino-NetoA. Human PLCG2 haploinsufficiency results in a novel NK cell immunodeficiency.J. Allergy Clin. Immunol.2024153240710.1016/j.jaci.2023.12.005 38123021
    [Google Scholar]
  27. HanB. XieQ. LiangW. YinP. QuX. HaiY. PLCG2 and IFNAR1: the potential biomarkers mediated by immune infiltration and osteoclast differentiation of ankylosing spondylitis in the peripheral blood.Mediators Inflamm.2024202411410.1155/2024/3358184 38223749
    [Google Scholar]
  28. ZhaoX. HuD. LiJ. ZhaoG. TangW. ChengH. Database mining of genes of prognostic value for the prostate adenocarcinoma microenvironment using the cancer gene atlas.BioMed Res. Int.2020202011010.1155/2020/5019793 32509861
    [Google Scholar]
/content/journals/ccdt/10.2174/0115680096307100240801095132
Loading
/content/journals/ccdt/10.2174/0115680096307100240801095132
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test